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Low back pain (LBP) is a recurrent and highly prevalent condition with significant health-related morbidity and a detrimental impact on society. 1 Chronic pain conditions, of which LBP constitutes a large proportion, are responsible for an estimated $61.2 billion per year in pain-related lost productive time in the United States. 2 The Public Health
Service Agency for Health Policy and Research evaluated strategies to treat LBP in 1994 and supported patient education, activity modification, nonsteroidal anti-inflammatory drugs, and acetaminophen. 3 A meta-analysis of 65 studies favored multidisciplinary treatment of LBP. 4 However, multidisciplinary treatment is not readily available to most patients with LBP symptoms. Therefore, the World Health Organization's Pain Relief Ladder, 5 developed for the management of cancer-related pain, is often applied to nonneoplastic pain. This may have contributed to the dramatic increase in opioid prescriptions and both open and percutaneous pain-relieving procedures. Between 1980Y1981 and 1999Y2000, the use of prescription opioids for chronic pain doubled, 6 and between 1994 and 2001, there was a 271% increase in lumbar epidural steroid injections (ESI) in the Medicare population. 7 This review was undertaken to quantitatively synthesize the existing literature on the treatment of LBP syndromes to aid informed decision-making by patients, clinicians, and other stakeholders such as government and insurance agencies. The objective of this study was to examine outcomes related to analgesia, patient function, mortality, and adverse effects (AE). For the purposes of this article, we have included complications ranging from individual medical risks to public health risks with respect to prescription drug abuse and diversion.
METHODS

Search Strategy
A comprehensive search was performed in Medline, EMBASE, PubMed, Cochrane Library, MD Consult, ClinicalTrials.gov, NIH RePORTer, MetaRegister of Current Controlled Trials, PsycInfo, and ISI Web of Knowledge to identify relevant fulllength articles in any language that were written up to September 2009. For articles on opioid analgesics, terms from any two of the following categories were searched: for Category I, LBP, back pain, backache, lumbar spine, radiculopathy, and neuropathic pain, and for Category II, opioids, opiates, morphine, hydromorphone, oxycodone, methadone, fentanyl, hydrocodone, oxymorphone, codeine, meperidine, propoxyphene, tramadol, and narcotics. For articles on spinal steroid injections, terms from any two of the following categories were searched: for Category III, LBP, radiculopathy, and intervertebral disc displacement, and for Category IV, epidural injections. The following keywords were searched: epidural steroid injection, facet joint injection, medial branch block, spinal nerve injection, spinal nerve block, and sacroiliac joint injection. The reference lists of selected articles were searched. Specific journals and authors' publications were searched. Pharmaceutical companies were also contacted for relevant studies that may not otherwise have been retrieved in our literature search.
Study Selection
Inclusion criteria were (1) open-label or blind prospective randomized controlled trials (RCTs); (2) study participants with nonneoplastic chronic LBP or lumbar radiculopathy; (3) subjects older than 18 yrs; (4) patients assigned to treatment using oral, sublingual, or transdermal opioids or interventions involving the delivery of steroid into the spinal canal, ESI, facet joint injections, medial branch blocks, and sacroiliac joint injections, and (5) having measured at least one predefined outcome. Studies with opioids were included regardless of pairing with other agents. Studies evaluating partial opioid agonists and synthetic opioid agonists were included. Studies pertaining to operative LBP, LBP in the immediate postoperative period, or parturition were excluded. Studies evaluating patients who had chronic LBP after spine surgery were included in our search. Individual studies may have excluded subjects who had aggressive titration of opioids or repeated spinal procedures; however, for the purposes of this metaanalysis, studies were not excluded based on these criteria. Quality was assessed using the Agency for Healthcare Research and Quality criteria, a 10-point assessment instrument. 8 We considered scores of quality. Titles and abstracts were reviewed by one author (D.E. Nampiaparampil). Four hundred fifty retrieved abstracts (10.8%) were reviewed by a second author (R.G. Nampiaparampil) to ensure interrater reliability. Content (D.E. Nampiaparampil) and noncontent experts (R.G. Nampiaparampil, G.M. Nampiaparampil) conducted independent evaluations. Disagreements were resolved through discussion or involvement of the third reviewer. Please refer to Figure 1 for a description of how the studies were selected.
Outcome Measures
Primary outcomes were low back or lower limb pain relief measured using the Visual Analog Scale (VAS), 9 functional benefit measured using the Oswestry Disability Index 10 and Roland-Morris Disability Questionnaire, 11 effects on quality-of-life as measured using the 36-item Short-Form Health Survey, 12 and mortality. We evaluated changes from baseline to the point of interest. In studies of axial low back and lower limb pain, if different values were attributed to VAS back and VAS leg, these scores were averaged to form a composite VAS score. Secondary positive outcomes included other measures of pain relief, functional benefit, effects on psychologic status, and effects on quality-of-life. Secondary negative outcome measures were AE including aberrant behaviors with respect to opioids, and procedural complications. These outcomes were assessed at (1) 1 wk, (2) between 1 wk and 1 mo, (3) between 1 and 3 mos, (4) between 3 and 6 mos, and (5) at a period longer than 6 mos.
Statistical Analysis
Results measured on the same continuous scale were used to compute mean treatment differences and 95% confidence intervals. The MantelHaentzel method was used to calculate summary estimates for AEs. Analysis was performed using SAS Version 9.1 (SAS Institute Inc, Cary, NC).
RESULTS
Oral and transdermal opioid preparations can have significant positive effects on the pain and disability associated with LBP. All-cause mortality was low in our analysis of patients attending specialty clinics. It was difficult to assess the AE of opioid therapy because they influenced up to 28% of patients to withdraw from the original studies.
Results of Studies on Opioid Therapy for Pain
One high-quality 13 and two moderate-quality studies 14,15 on 692 subjects reported on pain after treatment using oral or transdermal opioids. In the high-quality study, 13 the VAS difference between the opioid and control group (CG) was 15.5 (P G 0.001). Ruoff et al. 14 found a mean VAS difference of 7.9 (P = 0.015) between the opioid group and CG in the changes from baseline to the final visit on day 91 favoring opioid treatment. Standard deviations were not provided in the original study.
Results of Studies on Opioid Therapy for Function
In terms of function, none of the studies reported on the Oswestry Disability Index. Peloso et al. 13 demonstrated greater improvements in the opioid group on the Roland-Morris Disability Questionnaire Total score (P = 0.043) as well as on the bothersomeness subscale (P G 0.001) during a period of 91 days. No additional data were provided. Ruoff et al. 14 found improvements in the Roland-Morris Disability Questionnaire during a period of 91 days favoring the opioid-treated group (P e 0.027).
Results of Studies on Opioid Therapy
Peloso et al. 13 performed a high-quality double- 
Results of Studies on Spinal Steroid Injections Pain
Eight high-and medium-quality studies 16Y20,25Y27 comprising 814 subjects commented on pain as measured using the VAS (0Y100), with scores inversely proportional to pain.
Function
Five high-and medium-quality studies 16, 17, 20, 21, 23, 24 containing 654 subjects evaluated function as measured using the Oswestry Disability Index (0Y100), with scores inversely correlated to function. Figure 2 and Table 2 provide a pictorial summary of the high-and medium-quality study results with associated confidence intervals and statistical significance.
Three high-quality studies compared the blind epidural administration of an active steroid mixture with that of saline. 16Y19 Carette et al. 16 conducted a double-blind multicenter RCT comparing a series of up to three epidural injections of 8 ml (80 mg) methylprednisolone with 1 ml of saline in 158 adult patients with sciatica lasting 4 wks to 1 yr and found that epidural injections of methylprednisolone, compared with saline, resulted in mild to moderate improvement in leg pain as measured using the VAS (P = 0.03) and reduced the need for analgesics. Karppinen et al. 17, 18 performed a double-blind RCT at a university hospital in Helsinki. One hundred sixty patients aged 30Y65 yrs with unilateral lower limb radicular pain lasting 1Y6 mos were treated using fluoro-guided transforaminal epidural injections containing either 40 mg of methylprednisolone and 0.25% bupivacaine or saline. The total volume injected was 2 ml if the pathology was localized to L4 or L5 and 3 ml if the injection was performed at the S1 foramen. Patients received only one injection throughout the study duration. Recovery was better in the steroid group at 2 wks for leg pain (P = 0.02), straight leg raising (P = 0.03), lumbar flexion (P = 0.05), and patient satisfaction (P = 0.03). Back pain was significantly lower in the saline group at 3 mos (P = 0.03) and 6 mos (P = 0.002), whereas leg pain was significantly lower at 6 mos (P = 0.02).
Valat et al. 19 conducted a double-blind multicenter RCT in which they administered three epidural injections at 2-day intervals of either 2 ml (50 mg) of prednisolone or 2 ml of isotonic saline to 85 subjects with symptoms of lumbar radiculopathy lasting 5Y180 days. We determined that 56% of the steroid group and 34% of the CG had had successful outcomes as defined by patient reports of recovery or marked improvement at day 20. They concluded that although the use of epidural saline may be beneficial, the administration of epidural steroids provided no additional benefit. Patients were prohibited from using nonsteroidal anti-inflammatory drugs, and pursuit of alternative therapies was considered a treatment failure of the epidural injection. We concluded that there were 48 treatment failures of 85: 14 used nonsteroidal anti-inflammatory drug therapy (8 AG, 6 CG), 3 underwent surgery (1 AG, 2 CG), 2 underwent chemonucleolysis (1 from each group), and 5 pursued other spinal interventions (3 AG, 2 CG).
One high-quality study 20 compared the fluoroscopically guided epidural administration of an active steroid mixture to local anesthetic. Ng et al. 20 performed a double-blind RCT in the United Kingdom of 86 patients with LBP and lower limb pain Opioids vs. Steroid Injections in Back Pain that had not subsided using conservative treatment for 6 wks or more. Fluoroscopically guided transforaminal epidural injections were performed with the injection of either 2 ml of 0.25% bupivacaine + 40 mg of methylprednisolone or with 2 ml of 0.25% bupivacaine. Patients were not allowed to alter oral analgesics. We determined that periradicular infiltration (transforaminal epidural injection) provided sustained relief of radicular pain and improvement of LBP-related disability at 3 mos after the procedure. Thirty-five percent of patients in the bupivacaine and steroids group had at least a 10% reduction in the Oswestry Disability Index score at 3 mos, whereas 47.5% of patients in the bupivacaine-only group had at least a 20-mm reduction in leg pain compared with 41.5% of patients in the bupivacaine and steroids group. Corticosteroids showed no additional benefit when compared with local anesthetic when administered epidurally for LBP symptoms.
One high-quality study 21 compared the blind epidural administration of an active steroid mixture to the interligamentous administration of saline. Arden et al. 21 performed a double-blind multicenter RCT of 228 patients with unilateral lumbar radicular pain for 1Y18 mos who were being evaluated in specialty clinics. Subjects were excluded if they had spinal stenosis, previous lumbar spinal surgery, previous ESI, depression, or any ongoing litigation. The patients were randomized to receive either three lumbar ESIs of triamcinolone or interligamentous saline injections at 3-wk intervals. All patients treated using physical therapy and oral analgesics maintained these treatments. At 3 wks, the ESI group demonstrated a benefit over the CG, with patients achieving a 75% improvement in the Oswestry Disability Questionnaire, but no benefit was demonstrated at 6Y52 wks.
One high-quality study 22 compared blind epidural administration of an active steroid mixture with the interligamentous administration of a local anesthetic. A double-blind RCT was conducted on 93 surgical candidates for lumbar spinal surgery because of intractable pain. These patients had experienced 6 wks or more of pain attributed to lumbosacral radiculopathy from either disk herniation or spinal stenosis. These patients were randomly assigned to receive either an epidural injection or an intramuscular injection of 2 ml (80 mg) of methylprednisolone + 8 ml of bupivacaine 0.5%. All patients who reported insufficient pain relief with the control injection were offered a second ESI. Nine patients in the CG and seven in the AG underwent a second injection. An Bas treated[ analysis, performed because of the crossover, revealed no significant difference in the proportion of patients who had surgery among those who had at least one ESI compared with those who had not. At 35 days, there were complete records for 72 patients (77.4%), and analysis of these results revealed significant improvement in the epidural group over the intramuscular group (P G 0.004). There was no difference in long-term outcomes between the groups.
One high-quality study 23, 24 compared fluoroscopically guided administration of an active steroid mixture with local anesthetic for lumbar medial branch blocks, which are typically performed for lumbar facet osteoarthritis. A doubleblind RCT of fluoro-guided lumbar medial branch blocks by Manchikanti et al. 23, 24 assessed the effects of four different types of treatments. For the purposes of this review, only the patients who had had betamethasone + bupivacaine 0.25% or bupivacaine 0.25% injections were included. Each treatment group contained 15 patients who had 6 mos or more of chronic LBP who had been diagnosed with lumbar facet joint syndrome through comparative local anesthetic blocks using 1% lidocaine and 0.25% bupivacaine. The patients had to meet strict criteria of 80% pain relief per self-report with each injection, with the duration of pain relief meeting expected duration of action of each respective local anesthetic. Patients who underwent surgery in the past 3 mos were excluded from the study, as were patients with uncontrolled psychiatric disorders and/or uncontrolled or unstable and heavy opioid use. We found a significant improvement in pain and functional status at 3, 6, and 12 mos but could not decipher a significant difference between the two treatment groups.
Complications of Treatment Opioid Therapy
Only one RCT 15 assessed patients for the development of aberrant behaviors with respect to opioids. Jamison et al. 15 excluded patients with schizophrenia, delusional disorders, psychotic disorders, dissociative disorders, bipolar disorders, or ongoing treatment of drug or alcohol abuse who thus might be at higher risk of opioid misuse and abuse. 33 Of the selected patients, one exhibited aberrant behaviors related to opioid use. One patient took opioids during the nonopioid phase and was eventually lost to follow-up. A relatively small number of patients had difficulty with medication compliance (5.7%).
One high-quality 13 and two moderate-quality studies 14, 15 assessed opioid-related AEs. Jamison et al. 15 had three participants from the opioid groups (20%) discontinue therapy after 1 mo because of AEs including drowsiness, constipation, and dizziness. These participants were more likely to have worse pain intensity before treatment (P G 0.01), to be receiving compensation (P G 0.05), to smoke (P G 0.05), to have gained weight since the onset of pain (P G 0.05), and to be unemployed at the end of 1 yr (P G 0.05 
Complications of Spinal Steroid Injections
In the three high-quality studies 16, 18, 21 comprising 471 patients (241 in AG and 230 in CG), there was 0% prevalence of epidural hematoma, abscess, meningitis, discitis, thrombosis, seizure or arrhythmia, paralysis or paresis, nerve injury, or untoward systemic effects. Two patients from the Valat et al. 18 study were lost to follow-up without evaluation of possible complications. Forty-nine (10.4%) patients composed of 27 (11.2%) from the AG and 22 (9.6%) from the CG experienced headache related to dural puncture or other causes. Nonpositional headache is generally more common than postdural puncture headache. There appears to be no significantly increased risk of headache associated with spinal steroids compared with controls: odds ratio 1.29 (95% confidence interval, 0.69Y2.39).
DISCUSSION
It is commonly believed that long-term opioid therapy may be relatively more effective in patients who have multifactorial chronic LBP syndromes and that spinal steroid injections are most effective in patients who have acute LBP from an isolated cause. We postulate that most patients who use medical services for LBP typically fall along a spectrum of acute-on-chronic LBP that may be related to progressive structural degeneration from degenerative disk changes, facet osteoarthropathy, and/or other causes. Therefore, our meta-analysis included all patients meeting these criteria.
Our analysis revealed that opioid therapy is helpful in selected patients. In the combined tramadol 37.5 mg/acetaminophen 325 mg groups, it is possible that acetaminophen contributed to the outcomes. Acetaminophen inhibits N-methyl-D-aspartateY or substance PYmediated nitric oxide synthesis and inhibits prostaglandin E2 release in the spinal cord. 34, 35 However, these studies were included in our analysis because in clinical practice, patients are often prescribed combination-type medications.
Americans, who comprise 4.6% of the global population, consume 80% and 99% of the world's opioid and hydrocodone supplies, respectively. 36, 37 Between 1997 and 2006, there has been an overall increase in the amount of prescribed hydrocodone (244%), morphine (196%), oxycodone (732%), and methadone (1177%), perhaps because of the increase in the use of prescription opioids for nonneoplastic pain, 36 which has correlated with an increase in opioid-related morbidity and mortality. 38 An evaluation of the Drug Abuse Warning
Network demonstrated that the trend of increasing medical use of opioid analgesics did not seem to contribute to increases in the health consequences of opioid analgesic abuse. 39 In terms of diversion, 55.7% of a population 12 yrs or older who had admitted to using opioids for nonmedical purposes stated that they had received these drugs from a friend or relative for free, and 19.1% reported obtaining the drug from a doctor. 40 It was difficult to assess the risk of addiction or diversion in our analysis because patterns that may suggest addiction to prescribed opioids are (1) continued use despite harm, (2) compulsive use, and (3) craving. 41 It may be difficult to ascertain the true prevalence of prescription opioid addiction because this would necessitate providers continuing to prescribe despite their awareness of harm. Opioid-related mortality was low in our analysis of patients attending specialty clinics. This is supported by findings in a pain practice that showed that the prevalence of opioid-related deaths varied from 0.012%Y0.045% per year for 4 yrs. 42 Given the nature of specialty pain management clinics, these data may be a gross underestimation of the potential AEs of opioids in certain populations. Our analysis found that spinal steroid injections to the spine had a statistically significant www.ajpmr.com short-term benefit in terms of reduction of pain and enhancement of function but no significant long-term benefit compared with the CGs. It is unclear whether the use of local anesthetic or saline as a comparison group in the current literature is appropriate.
Historically, the inflammation associated with lumbar disk herniation was first treated in 1952 using Bperiradicular hydrocortisone[ or epidural steroids. 43 This successful trial was followed by effective caudal ESI of saline, lidocaine, and steroids administered both individually and in combination. 44 In 1972, small-volume ESI came into common practice. 45 Corticosteroids are thought to act by reducing inflammation and edema surrounding injured nerve roots and improving local circulation. 45 They may reduce the sensitization of dorsal horn neurons 46 and may suppress prostaglandins by inhibiting phospholipase A, 47 which, in turn, may decrease neurotransmitter release from primary afferent neurons and decrease spinal sensitization. 46, 48 Corticosteroids may directly inhibit neuronal excitation nociceptive C-fibers, 49 and local anesthetics may share this action. 50 Because both active and control groups improved with these injections, it is possible that there are additional mechanisms of action related to local anesthetic action or the effect of the volume of the injectate that need to be explored. Another possible explanation for the results is that the steroid was not delivered to the optimal target in the blind injections. In as many as 30% of the blind lumbar epidural injections performed by experienced practitioners, the epidural space was misidentified. 51 In a study of lumbar ESIs, in 25.7%
of cases, loss of air pressure resistance (which typically signifies epidural needle placement) was encountered while the needle tip was outside the spinal canal in the posterior back soft tissues. In 20.3% of procedures, the needle tip was positioned outside the epidural space at the base of the spinous process or overlying the facets, just posterior to the ligamentum flavum. 52 We found no studies that assessed the longterm effects of either opioids or corticosteroids on hypothalamic-pituitary-adrenal function in the form of hypogonadism 53 or insulin suppression. 54 In conclusion, review of the existent literature suggests that the use of both opioid therapy and percutaneous spinal delivery of steroids are helpful for LBP and disability. The high dropout rates caused by insufficient pain relief make it difficult to draw conclusions about opioid therapy for chronic LBP syndromes. There is more high-quality literature, with a larger number of subjects, studying the effects of steroid injections on chronic LBP syndromes compared with the amount of high-quality literature on the effects of opioid therapy. More data is necessary to draw meaningful conclusions about the use of long-term opioid therapy for these conditions. Table 2 provides a summary of all of the studies reviewed in this article. Of note, our study does not evaluate the outcomes of spine interventions, such as radiofrequency ablation of the lumbar medial branches, because these interventions do not involve the delivery of steroid into the spine. Conclusions on these therapies are outside the scope of this article.
